Neuroradiology

, Volume 46, Issue 4, pp 277–281 | Cite as

Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy

Diagnostic Neuroradiology

Abstract

Differences in prognosis and symptomatic treatment have highlighted the importance of the differential diagnosis of frontotemporal lobar degeneration (FTLD) and other dementias, but the variable clinical features make diagnosis difficult. We studied metabolic changes using multivoxel proton magnetic resonance spectroscopy (MRS) in regions of FTLD, including the posterior cingulate gyrus, which is also the area most affected by Alzheimer’s disease (AD) in the early stages. We examined six patients with FTLD, six with presumed AD, and five healthy volunteers using repetition and echo times of 2000 and 135 ms. We analysed peak ratios of choline (Cho), creatine (Cr), and N-acetylaspartate (NAA) from frontal and temporoparietal regions, basal ganglia, and posterior cingulate gyrus in both hemispheres. A decreased NAA/Cr ratio was observed in the posterior cingulate gyri in presumed AD (right: 1.56±0.44, P =0.011; left: 1.46±0.25, P =0.008) and FTD (right: 1.47±0.40, P =0.005; left: 1.36±0.32, P =0.002). No statistically significant changes in Cho/Cr were identified in the posterior cingulate gyri in presumed AD or FTLD, and no differences were observed in peak ratios in other regions. Decreased NAA may reflect neuronal activity in the posterior cingulate gyrus, and this study may contirbute to insights into the pathophysiology of FTLD.

Keywords

Frontotemporal lobar degeneration Senile dementia of Alzheimer type Posterior cingulate gyrus Magnetic resonance spectroscopy N-acetylaspartate 

References

  1. 1.
    Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D (1999) Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 66: 184–188PubMedGoogle Scholar
  2. 2.
    Mirra SS, Heyman A, McKeel D, et al (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41: 479–486PubMedGoogle Scholar
  3. 3.
    Brun A, Gustafson L (1976) Distribution of cerebral degeneration in Alzheimer’s disease. A clinico-pathological study. Arch Psychiatr Nervenkr 223: 15–33PubMedGoogle Scholar
  4. 4.
    Neary D, Snowden D, Gustafson JS, et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546–1554PubMedGoogle Scholar
  5. 5.
    Valenzuela MJ, Sachdev P (2001) Magnetic resonance spectroscopy in AD. Neurology 56: 592–598PubMedGoogle Scholar
  6. 6.
    Ernst T, Chang L, Melchor R, Mehringer CM (1997) Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 203: 829–836PubMedGoogle Scholar
  7. 7.
    Holshouser BA, Komu M, Moller HE, et al (1995) Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson’s disease: a multicenter pilot study. Magn Reson Med 33: 589–594PubMedGoogle Scholar
  8. 8.
    Hoang TQ, Bluml S, Dubowitz DJ, et al (1998) Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington’s and Parkinson’s diseases. Neurology 50: 1033-1040PubMedGoogle Scholar
  9. 9.
    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, WashingtonGoogle Scholar
  10. 10.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944PubMedGoogle Scholar
  11. 11.
    Kizu O, Yamada K, Nishimura T (2001) Proton chemical shift imaging in normal pressure hydrocephalus. AJNR 22: 1659–1664Google Scholar
  12. 12.
    Patel TB, Clark JB (1979) Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 184: 539–546PubMedGoogle Scholar
  13. 13.
    Urenjak J, Williams SR, Gadian DG, Noble M (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13: 981–989PubMedGoogle Scholar
  14. 14.
    Moats RA, Ernst T, Shonk TK, Ross BD (1994) Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32: 110–115PubMedGoogle Scholar
  15. 15.
    Hsu YY, Du AT, Schuff N, Weiner MW (2001) Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol 14: 145–166PubMedGoogle Scholar
  16. 16.
    Kantarci K, Jack CR Jr, Xu YC, et al (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease: a 1H MRS study. Neurology 55: 210–217PubMedGoogle Scholar
  17. 17.
    Parnetti L, Lowenthal DT, Presciutti O, et al (1996) 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer’s disease. J Am Geriatr Soc 44: 133–138PubMedGoogle Scholar
  18. 18.
    Parnetti L, Tarducci R, Presciutti O, et al (1997) Proton magnetic resonance spectroscopy can differentiate Alzheimer’s disease from normal aging. Mech Ageing Dev 97: 9–14PubMedGoogle Scholar
  19. 19.
    Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD (1993) Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 187: 433–437Google Scholar
  20. 20.
    Tedeschi G, Bertolino A, Lundbom N, et al (1996) Cortical and subcortical chemical pathology in Alzheimer’s disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 47: 696–704PubMedGoogle Scholar
  21. 21.
    Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol 42: 85–94PubMedGoogle Scholar
  22. 22.
    Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1: 103–116PubMedGoogle Scholar
  23. 23.
    Hugg JW, Kuzniecky RI, Gilliam FG, Morawetz RB, Fraught RE, Hetherington HP (1996) Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol 40: 236–239Google Scholar
  24. 24.
    Miller BL (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4: 47–52Google Scholar
  25. 25.
    Heiss WD, Kessler J, Szelies B, Grond M, Fink G, Herholz K (1991) Positron emission tomography in the differential diagnosis of organic dementias. J Neural Transm [Suppl 33]: 13–19Google Scholar
  26. 26.
    Ishii K, Sakamoto S, Sasaki M, et al (1998) Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 39: 1875–1878PubMedGoogle Scholar
  27. 27.
    Kaufer DI, Miller BL, Itti L, et al (1997) Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer’s disease. Neurology 48: 978–985PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Department of RadiologyKyoto Prefectural University of MedicineKyotoJapan

Personalised recommendations